Sign inJoin waitlistJoin the waitlist

Bonnie Lonze

Director, Research, NYU Langone Transplant Institute · NYU Grossman School of Medicine

Credentials: · · · · ·

History

Research · NYU Grossman School of Medicine
Present
Research · NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Johns Hopkins University School of Medicine
2013–2014
Surgery
Johns Hopkins University School of Medicine
2005–2012
MD from Johns Hopkins University, 2005
Johns Hopkins School of Medicine
2001–2005

Research

Function and regulation of CREB family transcription factors in the nervous system
Review · Neuron · 2002 · First of 2 authors · 1,789 citations
Desensitization in HLA-incompatible kidney recipients and survival
New England Journal of Medicine · 2011 · 542 citations
Results of Two Cases of Pig-to-Human Kidney Xenotransplantation
Case report · New England Journal of Medicine · 2022 · 394 citations

Dorry Segev
52 papers
Robert Montgomery
52 papers
Babak Orandi
24 papers · 10 as a resident
ND
Niraj Desai
22 papers
ND
Nabil Dagher
20 papers · 4 as a fellow
Nicole Ali
17 papers
NA
Nada Alachkar
14 papers
Andrew Singer
12 papers
EK
Edward Kraus
12 papers
Zoe Lewis
12 papers · 3 as a fellow
Jeffrey Stern
11 papers · 5 as a fellow
Vasishta Tatapudi
9 papers

Grants

Molecular Mismatch as a Marker for Immunologic Risk in Heart Transplant Recipients
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · New York University School of Medicine
2025–2030
A Prospective Clinical Trial of Immunosuppression Reduction in Recipients of Low Eplet Mismatched Renal Allografts: The Kidney for Life Initiative
National Institute of Allergy and Infectious Diseases · R34
Contact PI · $254.3K · New York University School of Medicine
2023–2024

Clinical trials

A Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney Transplantation
Principal investigator · Completed · Early phase 1
NYU Langone Health
2022–2024
A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
Principal investigator · Completed · Phase 2
NYU Langone Health
2020–2021